Falkenstern-Ge R F, Ingerl H, Kohlhäufl M
Division of Pulmonology, Klinik Schillerhoehe, Center for Pulmonology and Thoracic Surgery, Teaching Hospital of the University of Tuebingen, Solitude Street 18, Gerlingen, 70839 Stuttgart, Germany.
Case Rep Pulmonol. 2013;2013:361391. doi: 10.1155/2013/361391. Epub 2013 Apr 23.
Endoscopic lung volume reduction using lung sealant is a very new and innovative treatment option for patients with severe progressive and irreversible lung emphysema. A 55-year-old ex-smoker (60 pack years) referred to our center because of severe lung emphysema with progressive worsening of the obstructive ventilator pattern and clinical condition. We detected collateral channels of this patient by using the Chartis system. Therefore, we decided to treat the advanced emphysema of our patient with endoscopic volume reduction using lung sealant (AeriSeal). The foam of lung sealant AeriSeal is instilled into the peripheral airways and alveoli where it polymerizes and functions as tissue glue on the lung surface in order to seal the target region to cause durable irreversible absorption atelectasis. The follow-up evaluation 12 weeks later showed improved lung function (increased FEV 1/partial oxygen pressure/peripheral oxygen saturation and a reduction of TLC and RV) with improved quality of life. Correlation between changes in primary and secondary outcome measures in the lung function parameters and 6-minute-walking test before and 12 weeks after the application of lung sealant revealed significant reduction of hyperinflation and improvement both in the flow rates and in the physical capability of this patient.
使用肺密封剂的内镜下肺减容术是一种针对严重进行性和不可逆性肺气肿患者的全新且创新的治疗选择。一名55岁的戒烟者(吸烟史60包年)因严重肺气肿导致阻塞性通气模式和临床状况逐渐恶化而转诊至我们中心。我们使用Chartis系统检测到该患者的侧支通道。因此,我们决定采用肺密封剂(AeriSeal)进行内镜下肺减容术来治疗该患者的晚期肺气肿。将肺密封剂AeriSeal的泡沫注入外周气道和肺泡,在那里它聚合并在肺表面起到组织胶水的作用,以封闭目标区域,导致持久的不可逆吸收性肺不张。12周后的随访评估显示肺功能改善(第一秒用力呼气容积/分压/外周血氧饱和度增加,肺总量和残气量减少),生活质量提高。肺密封剂应用前和应用后12周的肺功能参数以及6分钟步行试验的主要和次要结局指标变化之间的相关性显示,该患者的肺过度充气明显减轻,流速和身体能力均有所改善。